Veracyte, Inc.
VCYT
Rank in Stocks
#4350
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Share Price
$44.93
Last synced: 2026-10-20
Market Cap
$3.61B
Change (1 day)
2.57%
Change (1 year)
24.45%
Country
US
Trade Veracyte, Inc. (VCYT)
Category
Healthcare
Revenue for Veracyte, Inc. (VCYT)
Revenue in Jun 2026 TTM: $561.90M
According to Veracyte, Inc. latest financial reports the company's current revenue (TTM) is $561.90M. In 2023 the company made a revenue of $361.05M an increase over the revenue in the year 2022 that was $296.54M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Veracyte, Inc. from 2011 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $561.90M | 26.05% |
| 2024 | $445.76M | 23.46% |
| 2023 | $361.05M | 21.76% |
| 2022 | $296.54M | 35.09% |
| 2021 | $219.51M | 86.85% |
| 2020 | $117.48M | -2.40% |
| 2019 | $120.37M | 30.82% |
| 2018 | $92.01M | 27.87% |
| 2017 | $71.95M | 10.55% |
| 2016 | $65.09M | 31.48% |
| 2015 | $49.50M | 29.62% |
| 2014 | $38.19M | 74.51% |
| 2013 | $21.88M | 88.20% |
| 2012 | $11.63M | 339.62% |
| 2011 | $2.65M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.34B | 8,146.31% |
US
|
|
| $25.11B | 4,368.23% |
US
|
|
| $2.71B | 381.77% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 1,211.98% |
US
|
